BEN-MAIMON CAROLE — SEC insider filings

SEC reporting owner CIK 1529611. 13 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2020-09-30 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Larimar Therapeutics, Inc. (LRMR)President and CEO, Director113 legs · 54,796 sh · $168,478—12
Teligent, Inc. (TLGT)Director2——2

Insider filings — BEN-MAIMON CAROLE

FiledFormIssuerReported transactionsSource
2026-11-124Larimar Therapeutics, Inc. (LRMR)Purchase (P): 18,050 @ $2.77EDGAR
2026-01-274Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 100,100 @ $0 · Grant/award (A): 600,600 (derivative) @ $0EDGAR
2025-01-244Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 91,000 @ $0 · Grant/award (A): 546,000 (derivative) @ $0EDGAR
2024-01-194Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 66,125 @ $0 · Grant/award (A): 396,750 (derivative) @ $0EDGAR
2023-05-184Larimar Therapeutics, Inc. (LRMR)Purchase (P): 5,000 @ $3.71EDGAR
2023-02-024Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 205,000 @ $0 · Grant/award (A): 325,000 (derivative) @ $0EDGAR
2022-09-194Larimar Therapeutics, Inc. (LRMR)Purchase (P): 31,746 @ $3.15EDGAR
2022-05-124Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-01-204Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 182,000 (derivative) @ $0EDGAR
2021-07-224Teligent, Inc. (TLGT)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2021-01-214Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 106,700 (derivative) @ $0EDGAR
2021-01-064Teligent, Inc. (TLGT)Grant/award (A): 2,000 (derivative) @ $0EDGAR
2020-09-304Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 411,400 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1529611 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs